Business / Finance

RSS

Mallinckrodt’s net sales increase $540.2M to 7.2% in first quarter 2014

Mallinckrodt plc, a global specialty pharmaceutical and medical imaging business, today reported results for the first quarter of fiscal 2014, which ended December 27, 2013. The company also announced revised guidance for fiscal 2014.

6 Feb 2014

Sound Physicians agrees to provide hospitalist services to Whidbey General Hospital

Sound Physicians, a leading hospitalist group based in Tacoma, Wash., has agreed to provide hospitalist services to Whidbey General Hospital beginning Feb. 5, 2014.

6 Feb 2014

Invacare reports net loss per share of $0.19 in fourth quarter 2013

Invacare Corporation today announced its financial results for the quarter and year ended December 31, 2013.

6 Feb 2014

UTHealth unveils country's first Mobile Stroke Unit

The University of Texas Health Science Center at Houston (UTHealth) Medical School, in partnership with Memorial Hermann-Texas Medical Center, has unveiled the country's first Mobile Stroke Unit.

6 Feb 2014

Neuland Laboratories announces financial results for third quarter of fiscal year 2014

Neuland Laboratories Ltd., (NSE:NEULANDLAB; BOM:524558) a pharmaceutical manufacturer providing active pharmaceutical ingredients (APIs), complex intermediates and contract manufacturing services to customers located in 85 countries, today announced financial results for the third quarter of fiscal year (FY) 2014, ended December 31, 2013.

5 Feb 2014

eInfochips launches Andromeda Reference Platform for medical imaging and telemedicine designers

The video processing system includes the system hardware and software that design teams need for fast time-to-application development

5 Feb 2014

Incyte enters into clinical trial collaboration agreement with Merck to evaluate safety of IDO1 inhibitor

Incyte Corporation (Nasdaq: INCY) announced today that it has entered into a clinical trial collaboration agreement with Merck, through a Merck subsidiary, to evaluate the safety and efficacy of Incyte's oral indoleamine dioxygenase-1 (IDO1) inhibitor, INCB24360, and Merck's investigational anti-PD-1 immunotherapy, MK-3475, in a Phase I/II study in previously treated metastatic and recurrent non-small cell lung cancer (NSCLC), and other advanced or metastatic cancers.

5 Feb 2014

Pfizer and Merck join forces to explore therapeutic potential of anti-PD-1 therapy

Pfizer Inc. announced today that it has agreed with Merck & Co., Inc., known as MSD outside the United States and Canada ("Merck"), through two Merck subsidiaries, to explore the therapeutic potential of Merck's investigational anti-PD-1 therapy, MK-3475, in combination with two Pfizer oncology assets.

5 Feb 2014

Spinifex announces results of Phase 2 clinical trial of EMA401 in postherpetic neuralgia

Spinifex Pharmaceuticals, an Australian pain drug development company, today announces that The Lancet has published the results of its Phase 2 clinical trial of its lead candidate, EMA401, in postherpetic neuralgia (PHN).

5 Feb 2014

Mayo Clinic, Minnesota Timberwolves, Lynx partner to extend Mayo Model of Care for patients

Mayo Clinic and the Minnesota Timberwolves and Lynx today announced a partnership which extends the Mayo Model of Care for patients in sports medicine to the Twin Cities.

5 Feb 2014

DePuy Synthes Spine signs representative agreement for marketing LifeNet Health's cellular allografts

DePuy Synthes Spine and DePuy Synthes Biomaterials, divisions of DePuy Orthopaedics, Inc., announced today they have entered into an exclusive worldwide representative agreement for the marketing and promotion of a new cellular allograft product developed by LifeNet Health, a world leader in allograft bio-implants and cellular therapies.

5 Feb 2014

OGT awarded NHS tender to supply oligo-based arrays for cytogenetics

Oxford Gene Technology, provider of innovative genetics research and biomarker solutions to advance molecular medicine, has been awarded a significant tender by the UK National Health Service for the supply of oligo-based arrays for cytogenetics.

From Oxford Gene Technology 4 Feb 2014

Domain Therapeutics, XOMA to jointly evaluate DTect-All to identify allosteric modulator antibodies

Domain Therapeutics, a biopharmaceutical company specializing in the research and development of new drug candidates targeting G protein-coupled receptors (GPCRs), today announces it has entered into a multi-step collaboration with XOMA Corporation, a leader in the discovery and development of therapeutic antibodies.

4 Feb 2014

Ablative Solutions completes $9.5M Series B Preferred Stock financing

Ablative Solutions, Inc., a privately-held clinical stage company headquartered in Kalamazoo, MI, with offices in Menlo Park, CA, announced today that it has completed a Series B Preferred Stock financing, totaling approximately $9.5 million (including the conversion of the bridge financing completed in 2013), to fund its unique technology platform for renal denervation.

4 Feb 2014

Hy-Vee collaborates with UNMC and Ferris State to offer rapid-diagnostic influenza test

Getting tested and treated for the flu and strep throat became much easier today in Omaha. It's now as convenient as a trip to the grocery store.

4 Feb 2014

Thermo Fisher Scientific acquires Life Technologies

Thermo Fisher Scientific, the world leader in serving science, today announced that it has completed its acquisition of Life Technologies Corporation (NASDAQ: LIFE) for $76.13 ($76.1311786) in cash per fully diluted common share, or approximately $13.6 billion, plus the assumption of $1.5 billion in net debt. The completion of the transaction follows the receipt of all required regulatory approvals.

4 Feb 2014

LLHC Group signs definitive stock purchase agreement with BioScrip

LHC Group Inc., a national provider of home health, hospice and comprehensive post-acute healthcare services, announced today that it has signed a definitive stock purchase agreement with BioScrip, Inc. to purchase two of its operating subsidiaries, doing business as Deaconess HomeCare and Elk Valley Health Services, for $60 million.

4 Feb 2014

Ferrer executes two agreements to support clinical studies of Lorediplon in insomnia patients

Ferrer, a privately-held Spanish pharmaceutical company, today announces that it has executed two agreements; with Ildong Pharmaceuticals Co Ltd, Korea and Ergomed Clinical Research Ltd, UK to support further clinical studies of Lorediplon in patients with insomnia.

3 Feb 2014

National Mentor Holdings enters into new senior secured credit facilities with Barclays Bank

National Mentor Holdings, Inc. today announced that it has entered into new senior secured credit facilities (the "New Senior Secured Credit Facilities") with Barclays Bank PLC, as administrative agent, and a syndicate of banks, to replace its existing senior secured credit facilities.

31 Jan 2014

Physio-Control enters into merger agreement with Sansio

Physio-Control, Inc., the world leader in emergency medical response technologies today announced it has entered into a merger agreement with Duluth, Minnesota-based Sansio - a leading provider of Software-as-a-Service (SaaS) solutions for the Emergency Medical Services (EMS) and home healthcare markets. The financial terms of the agreement were not disclosed.

31 Jan 2014

Business / Finance

Mallinckrodt’s net sales increase $540.2M to 7.2% in first quarter 2014

Sound Physicians agrees to provide hospitalist services to Whidbey General Hospital

Invacare reports net loss per share of $0.19 in fourth quarter 2013

UTHealth unveils country's first Mobile Stroke Unit

Neuland Laboratories announces financial results for third quarter of fiscal year 2014

eInfochips launches Andromeda Reference Platform for medical imaging and telemedicine designers

Incyte enters into clinical trial collaboration agreement with Merck to evaluate safety of IDO1 inhibitor

Pfizer and Merck join forces to explore therapeutic potential of anti-PD-1 therapy

Spinifex announces results of Phase 2 clinical trial of EMA401 in postherpetic neuralgia

Mayo Clinic, Minnesota Timberwolves, Lynx partner to extend Mayo Model of Care for patients

DePuy Synthes Spine signs representative agreement for marketing LifeNet Health's cellular allografts

OGT awarded NHS tender to supply oligo-based arrays for cytogenetics

Domain Therapeutics, XOMA to jointly evaluate DTect-All to identify allosteric modulator antibodies

Ablative Solutions completes $9.5M Series B Preferred Stock financing

Hy-Vee collaborates with UNMC and Ferris State to offer rapid-diagnostic influenza test

Thermo Fisher Scientific acquires Life Technologies

LLHC Group signs definitive stock purchase agreement with BioScrip

Ferrer executes two agreements to support clinical studies of Lorediplon in insomnia patients

National Mentor Holdings enters into new senior secured credit facilities with Barclays Bank

Physio-Control enters into merger agreement with Sansio

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Latest News